CARE™ hosts needs assessments with the aim of gathering feedback on current knowledge and management of various diseases in Canada. The results are shared with CARE™ commentary in follow-up publications. Our active Needs Assessments can be found below.
Needs Assessments
Open Needs Assessments
Hématologie
Évaluation des besoins de CARE™ : Lymphome diffus à grandes cellules B (LDGCB)
Le panorama changeant des traitements du lymphome et les autorisations récentes/anticipées des traitements du LDGCB ont incité les membres du Comité académique de CARE™ sur l’hématologie à mener une évaluation des besoins.
Questionnaire
Gastro-entérologie
Évaluation des besoins de CARE™ – Prise en charge des patients atteints d’une maladie inflammatoire de l’intestin
Ce d’évaluation des besoins de CARE™ porte principalement sur la pharmacovigilance thérapeutique, les stratégies de prise en charge et les occasions de formation offertes aux patients atteints d’une maladie inflammatoire de l’intestin (MII).
Questionnaire
Need Assessments Results
In Q1 of 2019 CARE™ conducted a Needs Assessment on Mantle Cell Lymphoma (MCL) that was directed at hematologists/oncologists across Canada. The aim of this CARE™ program was to gather...
In Q1 of 2019 CARE™ conducted a Needs Assessment on Mantle Cell Lymphoma (MCL) that was directed at hematologists/oncologists across Canada. The aim of this CARE™ program was to gather...
In an effort to promote a shared understanding of the range of issues, perspectives related to the use of asparaginase for adult Acute Lymphocytic Leukemia (ALL) patients in Canada, the...
The CARE Faculty recently conducted a needs assessment directed at Canadian oncologists and hematologists in the late Fall of 2017. The key focus of the needs assessment was assessing the...
This needs assessment was distributed by mail and electronically to upwards of 400 Canadian hematologists working in academic teaching centres and/or community practices. The response rate to this needs assessment...
